| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 24,796 | 18,945 | 33,679 | 28,518 | | Cost of Revenue | 22,061 | 21,202 | 35,275 | 23,830 | | | Gross Profit | 2,735 | (2,258) | (1,596) | 4,687 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,562 | 1,953 | 1,715 | 1,113 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,173 | (4,211) | (3,311) | 3,575 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (58) | (395) | 191 | 284 | | Earnings Before Interest And Taxes | 1,115 | (4,606) | (3,120) | 3,859 | | Interest Expense | 392 | 456 | 417 | 220 | | Income Before Tax | 722 | (5,062) | (3,537) | 3,639 | | Income Tax Expense | 134 | (2,194) | (1,343) | 1,545 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 588 | (2,868) | (2,195) | 2,094 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 588 | (2,868) | (2,195) | 2,094 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $588 | ($2,868) | ($2,195) | $2,094 |
|
0.51% Nasdaq 
Income Statement
